Literature DB >> 10088722

Prostaglandin E2 stimulates the formation of mineralized bone nodules by a cAMP-independent mechanism in the culture of adult rat calvarial osteoblasts.

H Kaneki1, I Takasugi, M Fujieda, M Kiriu, S Mizuochi, H Ide.   

Abstract

The effects of prostaglandin E2 (PGE2) on the proliferation and differentiation of osteoblastic cells were studied in osteoblast-like cells isolated from adult rat calvaria. Treatment of the cells with PGE2 within the concentration range 10(-8)-10(-5) M resulted in a dose-dependent increase in alkaline phosphatase (ALP) activity, [3H]proline incorporation into collagenase-digestible protein, and mineralized bone nodule (BN) formation, as well as a dose-dependent decrease in [3H]thymidine incorporation into the cells. PGE2 also caused a dose-dependent increase in the intracellular cyclic adenosine monophosphate (cAMP) content, with a maximal effective concentration of 10(-5) M; this effect of PGE2 was mimicked by forskolin, an adenylate cyclase activator. The treatment of adult calvarial cells with forskolin decreased BN formation, ALP activity, and collagen synthesis. These results suggested that cAMP does not have a stimulatory, but rather a suppressive, effect on the differentiation of adult rat calvarial cells. A time-course study of cAMP accumulation showed that both PGE2- and forskolin-induced cAMP reached a maximum at 5 min after the treatment, but the former rapidly returned to the basal level by 40 min, while the latter declined slowly and was still at 70% of the maximal level at 60 min, suggesting that PGE2 activates phosphodiesterase as well as adenylate cyclase. The presence of N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7), a calmodulin antagonist, reduced the rate of degradation of cAMP formed after PGE2 treatment, suggesting the involvement of calmodulin in the activation of phosphodiesterase. However, PGE2 also caused the production of inositol 1,4,5-triphosphate (IP3) and an elevation of the intracellular Ca2+ concentration ([Ca2+]i), both of which peaked at 15 s and returned to the basal level within 1 min. Submaximal responses of the IP3 production and the [Ca2+]i elevation to PGE2 were obtained at 10(-5) M. W-7 decreased both basal and PGE2-induced ALP activity, collagen synthesis and BN formation, indicating the involvement of Ca2+/calmodulin-dependent protein kinase in the PGE2-induced differentiation of calvarial cells. From these results, we concluded that PGE2 inhibits the proliferation and stimulates the differentiation of calvarial osteoblasts by elevating the [Ca2+]i through the activation of a phosphoinositide turnover, but not via an activation of adenylate cyclase. We also found that BN formation varies, depending on the time of PGE2 addition, suggesting that responsiveness of the cells to PGE2 may change during the culture period.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10088722

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  10 in total

1.  In vivo effects of two novel ALN-EP4a conjugate drugs on bone in the ovariectomized rat model for reversing postmenopausal bone loss.

Authors:  S Hu; C C Liu; G Chen; T Willett; R N Young; M D Grynpas
Journal:  Osteoporos Int       Date:  2015-08-14       Impact factor: 4.507

2.  Effects of selective prostaglandins E2 receptor agonists on cultured calvarial murine osteoblastic cells.

Authors:  Cynthia B Alander; Lawrence G Raisz
Journal:  Prostaglandins Other Lipid Mediat       Date:  2006-10-20       Impact factor: 3.072

3.  Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice.

Authors:  Manshan Xu; Shilpa Choudhary; Olga Voznesensky; Qi Gao; Douglas Adams; Vilmaris Diaz-Doran; Qian Wu; David Goltzman; Lawrence G Raisz; Carol C Pilbeam
Journal:  Bone       Date:  2010-05-13       Impact factor: 4.398

4.  Estrogen receptor-β regulates mechanical signaling in primary osteoblasts.

Authors:  Alesha B Castillo; Jason W Triplett; Fredrick M Pavalko; Charles H Turner
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-03-11       Impact factor: 4.310

5.  Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair.

Authors:  Xinping Zhang; Edward M Schwarz; Donald A Young; J Edward Puzas; Randy N Rosier; Regis J O'Keefe
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

6.  Age-related changes in bone morphology are accelerated in group VIA phospholipase A2 (iPLA2beta)-null mice.

Authors:  Sasanka Ramanadham; Kevin E Yarasheski; Matthew J Silva; Mary Wohltmann; Deborah Veis Novack; Blaine Christiansen; Xiaolin Tu; Sheng Zhang; Xiaoyong Lei; John Turk
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

7.  Cell differentiation and p38(MAPK) cascade are inhibited in human osteoblasts cultured in a three-dimensional clinostat.

Authors:  Louis Yuge; Izumi Hide; Takanori Kumagai; Yasuhiro Kumei; Sin'ichi Takeda; Masamoto Kanno; Masanori Sugiyama; Katsuko Kataoka
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Jan-Feb       Impact factor: 2.416

8.  Cyclooxygenase-2 gene disruption promotes proliferation of murine calvarial osteoblasts in vitro.

Authors:  Zheng Xu; Shilpa Choudhary; Yosuke Okada; Olga Voznesensky; Cynthia Alander; Lawrence Raisz; Carol Pilbeam
Journal:  Bone       Date:  2007-03-21       Impact factor: 4.398

9.  Immunohistochemical localization of key arachidonic acid metabolism enzymes during fracture healing in mice.

Authors:  Hsuan-Ni Lin; J Patrick O'Connor
Journal:  PLoS One       Date:  2014-02-07       Impact factor: 3.240

10.  The Expression of PHOSPHO1, nSMase2 and TNAP is Coordinately Regulated by Continuous PTH Exposure in Mineralising Osteoblast Cultures.

Authors:  D A Houston; K Myers; V E MacRae; K A Staines; C Farquharson
Journal:  Calcif Tissue Int       Date:  2016-07-21       Impact factor: 4.333

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.